Szyman Katie's most recent trade in Edwards Lifesciences Corp was a trade of 10,910 Common Stock done . Disclosure was reported to the exchange on Sept. 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 10,910 | 86,817 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.96 per share. | 03 Sep 2024 | 5,530 | 81,287 (0%) | 0% | 70.0 | 386,879 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.32 per share. | 07 Jul 2024 | 258 | 75,907 (0%) | 0% | 92.3 | 23,819 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.72 per share. | 11 May 2024 | 827 | 76,165 (0%) | 0% | 86.7 | 71,717 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 32,025 | 77,601 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.09 per share. | 07 May 2024 | 609 | 76,992 (0%) | 0% | 85.1 | 51,820 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,796 | 0 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2024 | 5,796 | 49,018 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.25 per share. | 03 May 2024 | 3,442 | 45,576 (0%) | 0% | 85.3 | 293,431 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.06 per share. | 03 May 2024 | 479 | 43,222 (0%) | 0% | 85.1 | 40,744 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 8,560 | 43,373 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Szyman Katie | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Feb 2024 | 27,000 | 61,813 (0%) | 0% | 36.8 | 992,250 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 85.62 per share. | 13 Feb 2024 | 27,000 | 34,813 (0%) | 0% | 85.6 | 2,311,654 | Common Stock |
| Edwards Lifesciences Corp | Szyman Katie | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 27,000 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Szyman Katie | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 86.46 per share. | 13 Feb 2024 | 20,000 | 34,813 (0%) | 0% | 86.5 | 1,729,200 | Common Stock |
| Edwards Lifesciences Corp | Szyman Katie | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Feb 2024 | 20,000 | 54,813 (0%) | 0% | 36.8 | 735,000 | Common Stock |
| Edwards Lifesciences Corp | Szyman Katie | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 20,000 | 27,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2023 | 5,000 | 47,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 10 Oct 2023 | 5,000 | 39,813 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 72.68 per share. | 10 Oct 2023 | 5,000 | 34,813 (0%) | 0% | 72.7 | 363,400 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 08 Sep 2023 | 5,000 | 39,813 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2023 | 5,000 | 52,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 08 Sep 2023 | 5,000 | 34,813 (0%) | 0% | 76 | 380,000 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 78.64 per share. | 09 Aug 2023 | 5,000 | 34,813 (0%) | 0% | 78.6 | 393,185 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 5,000 | 57,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 09 Aug 2023 | 5,000 | 39,813 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2023 | 5,000 | 62,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 90.52 per share. | 07 Jul 2023 | 5,000 | 34,813 (0%) | 0% | 90.5 | 452,600 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 07 Jul 2023 | 5,000 | 39,813 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.46 per share. | 07 Jul 2023 | 252 | 34,813 (0%) | 0% | 90.5 | 22,796 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 85.81 per share. | 13 Jun 2023 | 5,000 | 35,055 (0%) | 0% | 85.8 | 429,045 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 5,000 | 67,000 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.75 per share. | 13 Jun 2023 | 5,000 | 40,055 (0%) | 0% | 36.8 | 183,750 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 50,400 | 50,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 8,175 | 8,175 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 6,525 | 35,055 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 88.94 per share. | 07 May 2023 | 75,600 | 28,530 (0%) | 0% | 88.9 | 6,724,234 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.20 per share. | 07 May 2023 | 75,600 | 104,130 (0%) | 0% | 35.2 | 2,660,871 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 75,600 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 4,708 | 1,292 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2023 | 4,708 | 32,060 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 2,154 | 29,906 (0%) | 0% | 88.7 | 191,146 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.74 per share. | 07 May 2023 | 1,376 | 28,530 (0%) | 0% | 88.7 | 122,106 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.10 per share. | 03 May 2023 | 344 | 27,352 (0%) | 0% | 88.1 | 30,306 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.81 per share. | 03 May 2023 | 327 | 27,696 (0%) | 0% | 87.8 | 28,714 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 7,676 | 27,698 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2022 | 2,032 | 35,374 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.93 per share. | 17 May 2022 | 1,730 | 33,303 (0%) | 0% | 95.9 | 165,959 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 12,206 | 0 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2022 | 12,206 | 42,461 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.52 per share. | 07 May 2022 | 7,428 | 35,033 (0%) | 0% | 100.5 | 746,663 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.52 per share. | 07 May 2022 | 595 | 30,255 (0%) | 0% | 100.5 | 59,809 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 30,600 | 30,600 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 23,400 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 03 May 2022 | 23,400 | 54,743 (0%) | 0% | 21.8 | 509,184 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 105.10 per share. | 03 May 2022 | 10,449 | 30,850 (0%) | 0% | 105.1 | 1,098,173 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 104.18 per share. | 03 May 2022 | 9,155 | 41,299 (0%) | 0% | 104.2 | 953,739 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 4,725 | 4,725 | - | - | Performance Rights | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 105.88 per share. | 03 May 2022 | 3,796 | 50,454 (0%) | 0% | 105.9 | 401,916 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 3,775 | 31,343 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.93 per share. | 03 May 2022 | 493 | 54,250 (0%) | 0% | 105.9 | 52,223 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2022 | 20,000 | 23,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 11 Apr 2022 | 20,000 | 47,568 (0%) | 0% | 21.8 | 435,200 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 121.37 per share. | 11 Apr 2022 | 9,821 | 27,568 (0%) | 0% | 121.4 | 1,191,963 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 123.00 per share. | 11 Apr 2022 | 6,579 | 37,389 (0%) | 0% | 123.0 | 809,222 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 122.12 per share. | 11 Apr 2022 | 3,600 | 43,968 (0%) | 0% | 122.1 | 439,629 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 20,000 | 43,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 14 Mar 2022 | 20,000 | 47,414 (0%) | 0% | 21.8 | 435,200 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 104.88 per share. | 14 Mar 2022 | 11,853 | 27,414 (0%) | 0% | 104.9 | 1,243,178 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 104.31 per share. | 14 Mar 2022 | 8,147 | 39,267 (0%) | 0% | 104.3 | 849,823 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 20,000 | 63,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 18 Feb 2022 | 20,000 | 47,414 (0%) | 0% | 21.8 | 435,200 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 106.62 per share. | 18 Feb 2022 | 13,100 | 27,414 (0%) | 0% | 106.6 | 1,396,674 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 105.74 per share. | 18 Feb 2022 | 6,900 | 40,514 (0%) | 0% | 105.7 | 729,579 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 14 Jan 2022 | 10,000 | 37,414 (0%) | 0% | 21.8 | 217,600 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 10,000 | 83,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 119.47 per share. | 14 Jan 2022 | 8,884 | 27,414 (0%) | 0% | 119.5 | 1,061,329 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 120.01 per share. | 14 Jan 2022 | 1,116 | 36,298 (0%) | 0% | 120.0 | 133,934 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 121.24 per share. | 17 Dec 2021 | 10,000 | 27,414 (0%) | 0% | 121.2 | 1,212,400 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2021 | 10,000 | 93,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 17 Dec 2021 | 10,000 | 37,414 (0%) | 0% | 21.8 | 217,600 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2021 | 10,000 | 103,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 18 Nov 2021 | 10,000 | 37,414 (0%) | 0% | 21.8 | 217,600 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 117.88 per share. | 18 Nov 2021 | 6,357 | 27,414 (0%) | 0% | 117.9 | 749,394 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 116.98 per share. | 18 Nov 2021 | 2,390 | 33,771 (0%) | 0% | 117.0 | 279,586 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 118.87 per share. | 18 Nov 2021 | 1,253 | 36,161 (0%) | 0% | 118.9 | 148,947 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 18 Oct 2021 | 9,741 | 37,155 (0%) | 0% | 21.8 | 211,964 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2021 | 9,741 | 113,400 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 110.24 per share. | 18 Oct 2021 | 7,138 | 27,414 (0%) | 0% | 110.2 | 786,883 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 110.87 per share. | 18 Oct 2021 | 2,603 | 34,552 (0%) | 0% | 110.9 | 288,599 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 121.28 per share. | 08 Sep 2021 | 9,741 | 27,414 (0%) | 0% | 121.3 | 1,181,362 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2021 | 9,741 | 123,141 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 08 Sep 2021 | 9,741 | 37,155 (0%) | 0% | 21.8 | 211,964 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2021 | 344 | 27,414 (0%) | 0% | 0 | Common Stock | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 15,000 | 132,882 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 113.53 per share. | 02 Aug 2021 | 15,000 | 27,758 (0%) | 0% | 113.5 | 1,702,904 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.76 per share. | 02 Aug 2021 | 15,000 | 42,758 (0%) | 0% | 21.8 | 326,400 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 101.17 per share. | 15 Jun 2021 | 3,410 | 27,704 (0%) | 0% | 101.2 | 344,990 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2021 | 3,410 | 0 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.29 per share. | 15 Jun 2021 | 3,410 | 31,114 (0%) | 0% | 22.3 | 75,998 | Common Stock |
| Edwards Lifesciences Corp | Katie Szyman | CVP, Critical Care | Sale of securities on an exchange or to another person at price $ 96.10 per share. | 25 May 2021 | 4,665 | 29,765 (0%) | 0% | 96.1 | 448,300 | Common Stock |